4.7% placebo) also suggested an unfavorable trend toward harm, although the difference was not statistically significant.
← all excerpts
Developing New Drugs for the COVID-19 Emergency: Anatomy of the U.S. Response.
1
—
—
4.7% placebo) also suggested an unfavorable trend toward harm, although the difference was not statistically significant.